OrbiMed Capital GP IV LLC, Director, 10% Owner at Anthera Pharmaceuticals Inc (ANTH), sold 129,400 shares at $7.26 ($936K) on 2011-05-09, disclosed to the SEC on 2011-05-11.
Open-market sale of $936k ANTH by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.26 | 10,000 | $73K | 7.8% |
| 2 | $7.23 | 106,400 | $769K | 82.2% |
| 3 | $7.22 | 13,000 | $94K | 10.0% |
| Total | $7.23 avg | 129,400 | $936K | 100% |
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |